Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding

Obesity Surgery

Volumn 21, Issue 5, 2011, Pages 625-632

  Usinger, Lotte ^a   Hansen, Katrine B ^a   Kristiansen, Viggo B ^a   Larsen, Steen ^a   Holst, Jens J ^b   Knop, Filip K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

C peptide; Glucagon; Glucagon like peptide 1 (GLP 1); Glucose tolerance; Glucose dependent insulinotropic polypeptide (GIP); Incretin hormones; Insulin; Laparoscopic adjustable gastric banding (LAGB); Oral glucose tolerance test (OGTT)

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN; PARACETAMOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE RELEASE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STOMACH EMPTYING; WEIGHT REDUCTION;

ACETAMINOPHEN; ADULT; C-PEPTIDE; FEMALE; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GASTROPLASTY; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LAPAROSCOPY; MALE; MIDDLE AGED;

EID: 79955738765     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-011-0362-9     Document Type: Article

References (43)

1. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diab Care 27 5 1047 1053 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
3. KF Eriksson F Lindgarde 1991 Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 12 891 898 1778354 10.1007/BF00400196 1:STN:280: DyaK387jslGnuw%3D%3D
4. AJ Stunkard 1987 Conservative treatments for obesity Am J Clin Nutr 45 5 Suppl 1142 1154 3107369 1:STN:280:DyaL2s3gvFymtQ%3D%3D (Pubitemid 17081908)
5. H Buchwald Y Avidor E Braunwald, et al. 2004 Bariatric surgery: a systematic review and meta-analysis JAMA 292 14 1724 1737 15479938 10.1001/jama.292.14.1724 1:CAS:528:DC%2BD2cXos1OjtLg%3D (Pubitemid 39346675)
6. JB Dixon PE O'Brien 2002 Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding Diab Care 25 2 358 363 10.2337/diacare.25.2.358 (Pubitemid 41079636)
7. American Diabetes Association 2009 Standards of medical care in diabetes-2009 Diabetes Care 32 Suppl 1 S13 S61 10.2337/dc09-S013
8. SE Greenway FL Greenway 3rd S Klein 2002 Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 10 1109 1117 12361414 10.1001/archsurg.137.10.1109 (Pubitemid 35155242)
9. E Tiktinsky L Lantsberg S Lantsberg, et al. 2009 Gastric emptying of semisolids and pouch motility following laparoscopic adjustable gastric banding Obes Surg 19 9 1270 1273 19495893 10.1007/s11695-009-9887-6
10. M Willems AO Quartero ME Numans 2001 How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study Dig Dis Sci 46 10 2256 2262 11680606 10.1023/A:1011935603893 1:CAS:528:DC%2BD3MXot1KlsLg%3D (Pubitemid 32955241)
11. JJ Holst 2004 On the physiology of GIP and GLP-1 Horm Metab Res 36 11-12 747 754 15655703 10.1055/s-2004-826158 1:CAS:528:DC%2BD2MXnvFWltQ%3D%3D (Pubitemid 40115894)
12. R Chaikomin S Doran KL Jones, et al. 2005 Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects Am J Physiol Endocrinol Metab 289 3 E504 E507 15886226 10.1152/ajpendo.00099.2005 1:CAS:528:DC%2BD2MXhtVWksbrL (Pubitemid 41192706)
13. J Schirra M Katschinski C Weidmann, et al. 1996 Gastric emptying and release of incretin hormones after glucose ingestion in humans J Clin Invest 97 1 92 103 8550855 10.1172/JCI118411 1:CAS:528:DyaK28Xhtlajurc%3D (Pubitemid 26021698)
14. W Bablok H Passing R Bender B Schneider 1988 A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, part III J Clin Chem Clin Biochem 26 11 783 790 3235954 1:STN:280:DyaL1M7ns12hsA%3D%3D
15. C ∅rskov J Jeppesen S Madsbad JJ Holst 1991 Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine J Clin Invest 87 2 415 423 1991827 10.1172/JCI115012
16. T Krarup JJ Holst 1984 The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera Regul Pept 9 1-2 35 46 6505290 10.1016/0167-0115(84)90005-3 1:CAS:528:DyaL2MXosl0%3D (Pubitemid 14004800)
17. RC Heading J Nimmo LF Prescott P Tothill 1973 The dependence of paracetamol absorption on the rate of gastric emptying Br J Pharmacol 47 2 415 421 4722050 1:STN:280:DyaE3s3ivVajtg%3D%3D
18. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 412 419 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
19. M Matsuda RA DeFronzo 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diab Care 22 9 1462 1470 10.2337/diacare.22.9.1462 1:STN:280:DyaK1MvgvVertQ%3D%3D (Pubitemid 29418240)
20. NJ Wareham DI Phillips CD Byrne CN Hales 1995 The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion Diabet Med 12 10 931 8846687 10.1111/j.1464-5491.1995.tb00399.x 1:STN:280:DyaK287hsVGmtQ%3D%3D
21. K Kosaka T Kuzuya R Hagura H Yoshinaga 1996 Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus Diabet Med 13 9 Suppl 6 S109 S119 8894494 1:STN:280:DyaK2s%2FkvFOltA%3D%3D
22. T Kadowaki Y Miyake R Hagura, et al. 1984 Risk factors for worsening to diabetes in subjects with impaired glucose tolerance Diabetologia 26 1 44 49 6368299 10.1007/BF00252262 1:STN:280:DyaL2c7lvFartA%3D%3D (Pubitemid 14182349)
23. AE Chapman G Kiroff P Game, et al. 2004 Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review Surgery 135 3 326 351 14976485 10.1016/S0039-6060(03)00392-1 (Pubitemid 38297385)
24. SA Cunneen 2008 Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding Surg Obes Relat Dis 4 3 Suppl S47 S55 18501315 10.1016/j.soard.2008.04.007 (Pubitemid 351689962)
25. MA Maggard LR Shugarman M Suttorp, et al. 2005 Meta-analysis: surgical treatment of obesity Ann Intern Med 142 7 547 559 15809466
26. JB Buse S Caprio WT Cefalu, et al. 2009 How do we define cure of diabetes? Diab Care 32 11 2133 2135 10.2337/dc09-9036
27. U Hanusch-Enserer MA Ghatei E Cauza SR Bloom R Prager M Roden 2007 Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery Wien Klin Wochenschr 119 9-10 291 296 17571233 10.1007/s00508-007-0776-5 1:CAS:528:DC%2BD2sXpt1Grsb4%3D (Pubitemid 47011171)
28. AE Pontiroli F Folli M Paganelli, et al. 2005 Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study Diab Care 28 11 2703 2709 10.2337/diacare.28.11.2703 (Pubitemid 43951163)
29. AE Pontiroli D Gniuli G Mingrone 2010 Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT Obes Surg 20 4 474 479 20119734 10.1007/s11695-010-0076-4
30. HP Parkman AD Harris B Krevsky JL Urbain AH Maurer RS Fisher 1995 Gastroduodenal motility and dysmotility: an update on techniques available for evaluation Am J Gastroenterol 90 6 869 892 7771415 1:STN:280: DyaK2M3ovFehug%3D%3D
31. G Vantrappen 1994 Methods to study gastric emptying Dig Dis Sci 39 12 Suppl 91S 94S 7995225 1:STN:280:DyaK2M%2FoslGntQ%3D%3D
32. JR de Jong MG Besselink B van Ramshorst HG Gooszen AJ Smout 2010 Effects of adjustable gastric banding on gastroesophageal reflux and esophageal motility: a systematic review Obes Rev 11 4 297 305 19563457 10.1111/j.1467-789X.2009.00622.x
33. P Hladik J Vizda E Mala Z Zadak T Hroch 2008 The contribution of gastric emptying scintigraphy to the treatment of obesity with gastric bandage-preliminary results Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152 1 125 128 18795087
34. M Horowitz PJ Collins PE Harding DJ Shearman 1983 Abnormalities of gastric emptying in obese patients Gastroenterology 85 4 983 985 6884722 1:STN:280:DyaL3s3ovVCjtw%3D%3D
35. RA Wright S Krinsky C Fleeman J Trujillo E Teague 1983 Gastric emptying and obesity Gastroenterology 84 4 747 751 6825986 1:STN:280:DyaL3s7jtlSrsQ%3D%3D (Pubitemid 13152622)
36. E Bertin N Schneider N Abdelli, et al. 2001 Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy Diab Metab 27 3 357 364 1:STN:280:DC%2BD3MznsVGqtg%3D%3D (Pubitemid 32625389)
37. G Pacini A Mari 2003 Methods for clinical assessment of insulin sensitivity and beta-cell function Best Pract Res Clin Endocrinol Metab 17 3 305 322 12962688 10.1016/S1521-690X(03)00042-3 1:CAS:528:DC%2BD3sXmvVKmsLs%3D
38. MA Nauck E Homberger EG Siegel, et al. 1986 Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses J Clin Endocrinol Metab 63 2 492 498 3522621 10.1210/jcem-63-2-492 1:CAS:528:DyaL28XkvFWkt7g%3D (Pubitemid 16035703)
39. T Vilsbøll T Krarup S Madsbad JJ Holst 2003 Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects Regul Pept 114 2-3 115 121 12832099 10.1016/S0167-0115(03)00111-3 (Pubitemid 36773875)
40. A Flint A Raben A Astrup JJ Holst 1998 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans J Clin Invest 101 3 515 520 9449682 10.1172/JCI990 1:CAS:528:DyaK1cXosVagsg%3D%3D (Pubitemid 28084232)
41. CW Le Roux R Welbourn M Werling, et al. 2007 Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass Ann Surg 246 5 780 785 17968169 10.1097/SLA.0b013e3180caa3e3 (Pubitemid 350035654)
42. M Bose S Machineni B Olivan, et al. 2010 Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding Obesity (Silver Spring) 18 6 1085 1091 10.1038/oby.2009.473 1:CAS:528:DC%2BC3cXmsVGqsrw%3D
43. J Korner W Inabnet G Febres, et al. 2009 Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass Int J Obes (Lond) 33 7 786 795 10.1038/ijo.2009.79 1:CAS:528: DC%2BD1MXoslOhu7Y%3D